<DOC>
	<DOCNO>NCT00835757</DOCNO>
	<brief_summary>This study aim validate magnetic resonance image diffusion tensor imaging ( MRI/ DTI ) analysis non-invasive method assessment myelinated nerve fiber loss diabetic peripheral neuropathy .</brief_summary>
	<brief_title>Diffusion Tensor Imaging Sural Nerves Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>1 . Presence diabetes mellitus diagnose 6 month define World Health Organization Classification . 2 . Presence confirm DPN define . 3 . Age 1870 year . 4 . Have risk factor nondiabetic neuropathy ( determined medical history , family history , history medication , occupational history , history exposure toxins , physical neurological examination ) . 5 . Willingness provide informed consent cooperate medical procedure study . Inclusion Criteria Healthy Controls : 1 . Agematched nonobese ( BMI &lt; 30 ) control subject 2 . Normal glucose tolerance 3 . Normal blood pressure 4 . Normal lipid profile 5 . Free cause neuropathy describe . 1 . Nursing mother pregnant woman ( excluded positive pregnancy test ) . 2 . Patients history previous kidney , pancreas cardiac transplantation . 3 . Patients past history neuropathy ( independent diabetes ) , disease know associate neuropathy ( e.g . end stage renal disease , hepatitis C , systemic lupus erythematosus ) . 4 . Participation experimental medication trial within 3 month start study . 5 . Subjects implantable cardioverter defibrillator device would preclude MRI scan . 6 . Subjects unable unwilling comply experimental protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>